Skip to main content
  • rainbow over text: 'thank you NHS'
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Twist Bioscience Corporation (TWST) USD0.00001

Sell:$37.42 Buy:$37.50 Change: $2.03 (5.15%)
NASDAQ:0.17%
Market closed |  Prices as at close on 26 May 2020 | Switch to live prices |
Sell:$37.42
Buy:$37.50
Change: $2.03 (5.15%)
Market closed |  Prices as at close on 26 May 2020 | Switch to live prices |
Sell:$37.42
Buy:$37.50
Change: $2.03 (5.15%)
Market closed |  Prices as at close on 26 May 2020 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Twist Bioscience Corporation is a synthetic biology company. The Company is developing a disruptive deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company has a semiconductor-based synthetic DNA manufacturing process featuring 10,000-well silicon platform, which is capable of producing synthetic biology tools, such as genes, oligonucleotide pools and variant libraries. Its silicon-based DNA writing platform offers synthesis of genes on silicon. Its products include clonal perfect genes and non-clonal fragments. It offers protein scanning single variant libraries. Its design methodology, coupled with its silicon-based synthesis platform, enables synthesis of each library variant positioned exactly where user wants it to be. It offers unamplified oligo pools and cloning-ready oligo pools. Its platform offers synthesis of oligonucleotide pools for specific targeting.

Contact details

Address:
681 GATEWAY BLVD.
SOUTH SAN FRANCISCO
94080
United States
Telephone:
+1 (408) 4100105
Website:
https://www.twistbioscience.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
TWST
ISIN:
US90184D1000
Market cap:
$1.62 billion
Shares in issue:
40.98 million
Sector:
Biotechnology
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Emily Leproust
    Chairman of the Board, President, Chief Executive Officer
  • James Thorburn
    Chief Financial Officer
  • Patrick Weiss
    Chief Operating Officer
  • Mark Daniels
    Senior Vice President, Chief Legal Officer, Chief Ethics and Compliance Officer and Secretary
  • Martin Kunz
    Senior Vice President - Operation
  • Bill Peck
    Chief Technology Officer
  • Paula Green
    Vice President of Human Resources
  • Patrick Finn
    Chief Commercial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.